MediFind
Condition

Renal Oncocytoma

Symptoms, Doctors, Treatments, Research & More

Latest Research

Latest Advance
Study
  • Condition: Epidermal Growth Factor Receptor (EGFR) Wild-Type Lung Adenocarcinoma
  • Journal: Medicine
  • Treatment Used: Anlotinib
  • Number of Patients: 1
  • Published —
This study evaluated the effectiveness of salvage (form of therapy given after an ailment does not respond to standard therapy) anlotinib in heavily pretreated epidermal growth factor receptor (EGFR) wild-type lung adenocarcinoma (type of lung cancer).
Latest Advance
Study
  • Condition: Localized Prostate Cancer After Radical Prostatectomy
  • Journal: The Lancet. Oncology
  • Treatment Used: Adjuvant Radiotherapy Versus Early Salvage Radiotherapy Plus Short-Term Androgen Deprivation Therapy
  • Number of Patients: 424
  • Published —
The purpose of the study was to compare adjuvant versus early salvage radiotherapy after radical prostatectomy, combined with short-term hormonal therapy, in terms of oncological outcomes and tolerance.
Latest Advance
Study
  • Condition: Adenocarcinoma of the Prostate
  • Journal: The Lancet. Oncology
  • Treatment Used: Adjuvant Radiotherapy Versus Early Salvage Radiotherapy Following Radical Prostatectomy
  • Number of Patients: 333
  • Published —
The purpose of the study was to compare disease progression between patients given adjuvant radiotherapy and those given salvage radiotherapy.
Latest Advance
Study
  • Condition: Bladder Adenocarcinoma
  • Journal: F1000Research
  • Treatment Used: Partial Cystectomy plus Extended Lymphadenectomy
  • Number of Patients: 1
  • Published —
This case report describes a patient that was diagnosed as having a recurrent urinary tract infection but instead had bladder adenocarcinoma and was treated using a partial cystectomy plus extended lymphadenectomy.
Latest Advance
Study
  • Condition: Spine Tumors in Nigeria
  • Journal: Nigerian journal of clinical practice
  • Treatment Used: Gross Resection
  • Number of Patients: 472
  • Published —
This study identified the pattern of presentation and surgical management of spine tumors in southeast Nigeria.
Latest Advance
Study
  • Condition: Possible Follicular Neoplasm of Thyroid
  • Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)
  • Treatment Used: Elective Lymph Node Dissection
  • Number of Patients: 80
  • Published —
This study assessed elective central lymph node dissection on staging and early surgical complications in patients undergoing surgery for suspicion for follicular neoplasm or oxyphilic neoplasm of thyroid.
Latest Advance
Study
  • Condition: HER2-Positive Gastric Cancer
  • Journal: The New England journal of medicine
  • Treatment Used: Trastuzumab Deruxtecan
  • Number of Patients: 187
  • Published —
The study researched the safety and effectiveness of Trastuzumab Deruxtecan in treating HER2-positive gastric cancer.
Latest Advance
Study
  • Condition: Collision Cancer of Primary Squamous Cell Carcinoma (SCC) and Adenocarcinoma in Stomach after Treatment for Non-Hodgkin's Lymphoma of Diffuse Large B Cell Type
  • Journal: Nihon Shokakibyo Gakkai zasshi The Japanese journal of gastro-enterology
  • Treatment Used: Total Gastrectomy, Distal Pancreatectomy, Splenectomy, D2 Lymph Node Dissection, and Adjuvant Chemotherapy
  • Number of Patients: 1
  • Published —
This case report discusses a 61-year-old woman with a collision cancer of primary squamous cell carcinoma (SCC) and adenocarcinoma in the stomach treated with total gastrectomy, distal pancreatectomy, splenectomy, D2 lymph node dissection, and adjuvant chemotherapy with S-1.
Latest Advance
Study
  • Condition: Siewert type II adenocarcinoma of esophagogastric junction
  • Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
  • Treatment Used: Cheng's Giraffe reconstruction
  • Number of Patients: 34
  • Published —
The study researched the effects of Cheng's Giraffe reconstruction on patients with Siewert type II adenocarcinoma of esophagogastric junction.
Latest Advance
Study
  • Condition: Pre-treated Patients with Epidermal Growth-Factor Receptor (EGFR)-Mutated or Anaplastic Lymphoma Kinase (ALK)-Translocated Lung Adenocarcinoma
  • Journal: Medicine
  • Treatment Used: Programmed Cell-Death-Protein-1 and Its Ligand Inhibitors
  • Number of Patients: 51
  • Published —
This study determined the effectiveness against epidermal growth-factor receptor (EGFR)/anaplastic lymphoma kinase (ALK)/c-ros oncogene 1 (ROS1)-mutated non-small cell lung cancer (NSCLC).
Latest Advance
Study
  • Condition: Locally advanced pulmonary adenocarcinoma
  • Journal: Medicine
  • Treatment Used: Neoadjuvant apatinib plus S-1
  • Number of Patients: 1
  • Published —
The study researched the effects of neoadjuvant apatinib plus S-1 for locally advanced pulmonary adenocarcinoma.
Latest Advance
Study
  • Condition: 6-Year-Old Child with Clear Cell Adenocarcinoma of the Cervix (CCAC)
  • Journal: Medicine
  • Treatment Used: Fertility-Preserving Local Excision under Hysteroscope with Combined Chemotherapy (CT)
  • Number of Patients: 1
  • Published —
This case report discusses a a 6-year-old child with clear cell adenocarcinoma of the cervix treated with fertility-preserving local excision under a hysteroscope with combined chemotherapy (CT).